Trumps FDA Cuts Are Putting Drug Development at Risk
www.wired.com
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musks cost-cutting measures could slow drug research and delay FDA approvals.
0 Comentários ·0 Compartilhamentos ·42 Visualizações